Business

DSMB Recommends Continuation of Cynatas MEND Trial

DSMB Recommends Continuation of Cynatas MEND Trial

articleCynata Therapeutics LimitedOctober 7, 20215/company/cynata-therapeutics-ltd/news/dsmb-recommends-continuation-of-cynatas-mend-trial
DSMB Recommends Continuation of Cynatas MEND Trial

About this update from Cynata Therapeutics Limited

[{"type":"text","content":"Cynata Therapeutics Ltd has released a press release. View Attachment","length":233,"tagName":"div"}]

More updates from Cynata Therapeutics Limited